Rare diseases
Investigational molecules
Locations
Study of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control
FrancePhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
BelgiumEfficacy and safety of osilodrostat with drug combination in patients with hypertension caused by Cushing's syndrome
BulgariaPhase 2 Study of Imzokitug with drug combination as First‑Line Treatment for Adults with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer (NSCLC)
FranceEfficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia
BulgariaPharmacokinetics, Safety and Efficacy of Nemolizumab in Infants 6–23 Months with Moderate-to-Severe Atopic Dermatitis
PolandStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
AustriaEfficacy and safety of dexibuprofen (S‑ibuprofen) gel versus placebo for pain relief in patients with acute soft‑tissue contusions, with background paracetamol
GermanyEfficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes
GermanyA Phase 3 Study of Engasertib to Evaluate Safety and Effectiveness in Adults with Moderate to Severe Hereditary Hemorrhagic Telangiectasia
BelgiumLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
BelgiumSafety and efficacy of oral ACT-777991 in adults with non‑segmental vitiligo: a randomized, double‑blind, placebo‑controlled Phase 2a trial
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
